feed,title,long_url,short_url
Benzinga,AIM ImmunoTech Plans To Evaluate Two Forms Of Ampligen In Early-COVID-19 Disease,https://benzinga.com/general/biotech/21/09/23137845/aim-immunotech-plans-to-evaluate-two-forms-of-ampligen-in-early-covid-19-disease,https://j.mp/3obV5Pj
Benzinga,Why Are Ondas Shares Trading Higher Today?,https://benzinga.com/news/21/09/23140888/why-are-ondas-shares-trading-higher-today,https://j.mp/2ZvoLwo
